Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke Bilcke

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2022
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison StudyXiao Li, David Hodgson, Julien Flaig, et al.
Future Microbiology|December 10, 2009
Rotavirus disease and vaccination: impact on genotype diversityJelle Matthijnssens, Joke Bilcke, Max Ciarlet, et al.
The Lancet. Infectious Diseases|May 28, 2019
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling studyJoke Bilcke, Marina Antillón, Zoë Pieters, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2016
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014Martine Sabbe, Nicolas Berger, Adriaan Blommaert, et al.
Scientific Reports|December 22, 2015
Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?Virginia E Pitzer, Joke Bilcke, Elisabeth Heylen, et al.
The Lancet. Infectious Diseases|February 6, 2022
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling studyRuthie Birger, Marina Antillón, Joke Bilcke, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country EvaluationXiao Li, Ernest O Asare, Jiye Kwon, et al.
Clinical and Vaccine Immunology : CVI|January 17, 2014
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatriciansBenson Ogunjimi, Evelien Smits, Steven Heynderickx, et al.
BMC Medicine|April 2, 2023
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaMihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2022
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison StudyXiao Li, David Hodgson, Julien Flaig, et al.
Future Microbiology|December 10, 2009
Rotavirus disease and vaccination: impact on genotype diversityJelle Matthijnssens, Joke Bilcke, Max Ciarlet, et al.
The Lancet. Infectious Diseases|May 28, 2019
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling studyJoke Bilcke, Marina Antillón, Zoë Pieters, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2016
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014Martine Sabbe, Nicolas Berger, Adriaan Blommaert, et al.
Scientific Reports|December 22, 2015
Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?Virginia E Pitzer, Joke Bilcke, Elisabeth Heylen, et al.
The Lancet. Infectious Diseases|February 6, 2022
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling studyRuthie Birger, Marina Antillón, Joke Bilcke, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country EvaluationXiao Li, Ernest O Asare, Jiye Kwon, et al.
Clinical and Vaccine Immunology : CVI|January 17, 2014
Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatriciansBenson Ogunjimi, Evelien Smits, Steven Heynderickx, et al.
BMC Medicine|April 2, 2023
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaMihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, et al.
Pageof 6